Showing results (21-30 of 801) with videos related to
Sort By:
Pageof 81
Haematologica|May 1, 1992
A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulinsF Rodeghiero, C Schiavotto, G Castaman, et al.Thrombosis and Haemostasis|October 5, 2001
Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosisG Castaman, A Tosetto, M Simioni, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Desmopressin and type II B von Willebrand diseaseG Castaman, F RodeghieroThrombosis and Haemostasis|December 18, 1987
Calibration of lyophilized standards for ristocetin cofactor activity of von Willebrand Factor (vWF) requires vWF-deficient plasma as diluent for dose-response curvesF Rodeghiero, G CastamanBest Practice & Research. Clinical Haematology|November 1, 2001
Congenital von Willebrand disease type I: definition, phenotypes, clinical and laboratory assessmentF Rodeghiero, G CastamanLeukemia|January 1, 1994
The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemiaF Rodeghiero, G CastamanHaematologica|November 1, 1993
Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemiaG Castaman, F RodeghieroLa Ricerca in Clinica E in Laboratorio|April 1, 1990
The von Willebrand factorF Rodeghiero, G CastamanAmerican Journal of Hematology|August 1, 1995
Platelet von Willebrand factor abnormalities in myeloproliferative syndromesG Castaman, A Lattuada, M Ruggeri, et al.Pageof 81